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BRIEF COMMUNICATION
A RAPID LATEX AGGLUTINATION TEST FOR THE DETECTION OF ANTI-CYSTICERCUS ANTIBODIES
IN CEREBROSPINAL FLUID (CSF)
Sérgio M. ROCHA(1), Lisandra A. SUZUKI(1), Andréa D.T. da SILVA(1), Gisele C. ARRUDA(1,2) & Cláudio L. ROSSI(1)
SUMMARY
Simple and rapid latex-based diagnostic tests have been used for detecting specific antigens or antibodies in several diseases. In
this article, we present the preliminary results obtained with a latex agglutination test (LAT) for diagnosing neurocysticercosis by
detection of antibodies in CSF. A total of 43 CSF samples were assayed by the LAT: 19 CSF samples from patients with neurocysticercosis
and 24 CSF samples from patients with other neurologic disorders (neurosyphilis, n = 8; neurotoxoplasmosis, n = 3; viral meningitis,
n = 4, chronic headache, n = 9). The LAT exhibited 89.5% sensitivity and 75% specificity. The use of LAT seems to be an additional
approach for the screening of neurocysticercosis with advantage of simplicity and rapidity. Further studies could be performed using
purified antigens and serum samples.
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Cysticercosis is an important health problem in many countries of
Asia, Africa and Latin America with inadequate sanitary conditions1,6.
The disease is caused by infection with the larval form (cysticercus) of
the pork tapeworm Taenia solium. The cysticerci may be located in areas
where they produce no symptoms, such as muscle or cutaneous tissues.
On the other hand, the presence of cysticerci in the central nervous system
(CNS), a condition known as neurocysticercosis, can cause seizures and
other neurologic problems. The clinical manifestations of neurocys-
ticercosis are nonspecific and varied and depend on the number, size,
age, localization and evolutionary stage of cysticerci in the SNC6,7. Thus,
the definitive diagnosis of neurocysticercosis should always be considered
in an epidemiological context and confirmed by neuro-imaging
techniques3 (computed tomography or nuclear magnetic ressonance) and/
or detection of specific antibodies in cerebrospinal fluid (CSF)4-5. Several
tests have been used for the immunodiagnosis of neurocysticercosis such
as complement fixation (CFT), immunoelectrophoresis (IEE), indirect
hemagglutination (IHT), indirect immunofluorescence (IFT), enzyme-
linked immunosorbent assay (ELISA) and enzyme-linked immunoelec-
trotransfer blot (EIBT) assay4,5,7. The performance of immunoenzymatic
techniques is superior to other techniques for the immunodiagnosis of
neurocysticercosis. However, these techniques require several laboratory
equipments and highly skilled personnel. Hence, development of simple,
rapid and sensitive methods for detecting antibodies against T. solium
cysticerci are needed. Simple and rapid latex-based diagnostic tests have
been used for detecting specific antigens or antibodies in several diseases2.
In this article, we present the preliminary results obtained with a latex
agglutination test (LAT) for diagnosing neurocysticercosis by detection
of antibodies in CSF.
All chemicals were reagent grade or better and, unless otherwise stated,
were obtained from Sigma Chemical Co., St. Louis, Missouri, USA.
The Cysticercus antigen was prepared as previously described4, with
a few modifications. Briefly, frozen cysts were quickly thawed and
resuspended in phosphate buffered saline (PBS) 0.15 M pH 7.2
containing protease inhibitors [5 mM phenylmethylsulfonyl fluoride
(PMSF) and 0.0025 mM leupeptin] to about three times the cysticerci
volume and the material was homogeneized in an ice-water bath using a
Polytron homogeneizer (Brinkmann Instruments, Inc., Westbury, New
York, USA) equipped with a PT-20 ST probe. Homogeneization was
accomplished in three 30-sec pulses with the probe speed set at 3 and
the pulses separated by a 30-sec pause for sample cooling. The
homogenate was sonicated in an ice-water bath using a Branson Sonicator
(model SX-30, Branson Ultrasonics, Danbury, USA). Sonication was
accomplished with a 20% pulse dute in three 1-min pulses with the probe
speed set at 3 and the pulses separated by a 1 min pause for sample
cooling. Protease inhibitors PMFS and leupetin were added to sonicated
material as previously described and the suspension was gently stirred
for 16 hours at 5 oC. The material was centrifuged at 20,000 g for 1 h at
4 oC. The supernatant was carefully removed, filtered through 0.45 	m
filters (Millex filters, Millipore Corporation, USA), and was stored in
aliquots at – 80 oC until used.
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Carboxyl-modified polystyrene latex microspheres (0.77 	m diameter,
100 mg/ml, Bangs Laboratories, Fishers, USA) were used in the agglutination
test. After homogeneization, 0.5 ml of the latex suspension was washed
with MES [2-(n-morpholino)-ethanesulfonic acid] buffer, pH 5.5 (activation
buffer), twice by centrifugation at 13,000 rpm for 10 min each time, and the
microspheres were ressuspended in same buffer to 10 mg/ml. For covalent
coupling of Cysticercus antigen to microspheres, 50 mg of 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide freshly dissolved in 0.5 ml of water
were added to latex suspension and the mixture was gently stirred for 15
min. The material was then washed with MES buffer, pH 7.2 (coupling
buffer) as previously described and the microspheres were resuspended in
the same buffer to 2.5 ml. The material was transfered to a becker and mixed
with an equal volume of Cysticercus antigen diluted to 1 mg/ml with the
coupling buffer. The mixture was incubated at room temperature for 3 h
with constant shaking and then 1 ml of a 10% solution of bovine serum
albumin (BSA) in coupling buffer was added. After an incubation of 30
min, the microspheres were washed with PBS 0.15 M pH 7.4 containing
0.1% BSA and the latex particles were resuspended in the same buffer to 10
mg/ml. The sensitized latex particles were stored at 4 oC until use.
A total of 43 CSF samples were assayed by the LAT: 19 CSF samples
from patients with neurocysticercosis and 24 CSF samples from patients
with other neurologic disorders (neurosyphilis, n = 8; neurotoxoplasmosis,
n = 3; viral meningitis, n = 4, chronic headache, n = 9). All 19 patients with
neurocysticercosis had evidence of cystic lesions on computed tomography.
All 24 patients with other neurological disorders had no significant
epidemiologic, clinical or neuro-imaging data for neurocysticercosis.
The LAT was performed by mixing 40 	l of the sensitized latex with
40 	l of the CSF sample on a glass slide. Positive and negative controls
were included in each assay. The slide was gently rotated and rocked for 2
min, and the reactions were visually observed. Reactions presenting a
clear agglutination of latex particles were recorded as positive.
The LAT results of all the CSF tested are shown in the Table 1.
Positive reactions were detected in 17 of 19 patients with neurocys-
ticercosis and in 6 of 24 patients with other neurological disorders. Four
neurosyphilis CSF samples and two neurotoxoplasmosis CSF samples
had positive LAT results. Based on these results the LAT exhibited 89.5%
sensitivity and 75% specificity.
The detection of specific antibodies against T. solium cysticerci
antigens in CSF from patients suspected of having neurocysticercosis is
an additional tool for the diagnosis. However, when the immunological
tests are performed with a whole cysticerci extract, there are a significant
number of false-positive results because the cross-reactivity with other
parasitic diseases, including syphilis and toxoplasmosis4.
Numerous latex-based assays have found commercial applications.
Advantages include assay speed, simplicity, low cost of manufacture
and lack of a requirement for sophisticated laboratory equipments2. The
use of LAT seems to be an additional approach for the screening of
neurocysticercosis with advantage of simplicity and rapidity. Further
studies could be performed using purified antigens and serum samples.
RESUMO
Teste rápido de aglutinação utilizando partículas de látex para a
detecção de anticorpos anti-cisticercos em amostras de líquido
cefalorraquidiano (LCR)
Testes diagnósticos simples e rápidos baseados na aglutinação de
partículas de látex têm sido utilizados para a pequisa de antígenos ou
anticorpos específicos em muitas doenças. No presente trabalho, é descrito
um teste de aglutinação em lâmina para a pesquisa de anticorpos contra
cisticercos de Taenia solium, utilizando partículas de látex revestidas com
um extrato bruto do parasita. Anticorpos anti-cisticercos foram pesquisados
em 19 amostras de LCR de pacientes com neurocisticercose e em 24
amostras de LCR de pacientes com outros problemas neurológicos
(neurosífilis, n = 8; neurotoxoplasmose, n = 3; meningite viral, n = 4;
cefaléia crônica, n = 9). O teste de aglutinação apresentou sensibilidade e
especificidade de 89,5% e 75%, respectivamente. O teste de aglutinação
para cisticercose idealizado é simples, rápido e barato. Essas características
tornam o teste um meio promissor de expansão e simplificação do
imunodiagnósico da neurocisticercose. Estudos futuros poderiam testar a
sensibilização das partículas de látex com antígenos de cisticercos
purificados e a pesquisa de anticorpos em amostras de soros.
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Table 1
LAT results in CSF samples from patients with different neurological disorders
Diagnosis Agglutination reactions
Positive Negative
Neurocysticercosis (n = 19) 17 2
Neurosyphilis (n = 8) 4 4
Neurotoxoplasmosis (n = 3) 2 1
Viral meningitis (n = 4) 0 4
Chronic cefalea (n = 9) 0 9
